MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI+

Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and Physicians

CLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM Software Inc., a leading global provider of medical imaging software, announced U.S. Food and Drug Administration (FDA) clearance of its newest AI auto-contouring solution, Contour ProtégéAI+™.

Contour ProtégéAI+ from MIM Software
Contoured medical images float from right to left.

New Zero-Click AI Auto-Contouring Solution Gives Cancer Treatment Planners More Time for Plan Evaluation

  • Contour ProtégéAI+ auto-contouring launches automatically when each patient is simulated. Clinicians don’t need to do anything to start the process.
  • Head & neck and breast lymph node level structures are generated, along with OAR (organs at risk) structures.
  • Auto-contours appear where they are needed for review – in the TPS or MIM®.

Unlike other auto-contouring tools, Contour ProtégéAI+ requires no clicks. Contouring of lymph node level and OAR structures starts automatically, and no manual intervention is required to launch. Results are exported directly to the TPS or MIM for review. This gives dosimetrists and physicians more time to create quality treatment plans for their patients.

“Cancer treatment planning teams should have as much time as possible to focus on developing precise, individualized treatment plans,” said Jay Obman, Product Manager at MIM Software Inc. “The MIM team is thrilled that zero-click auto-contouring of lymph node level and OAR structures with Contour ProtégéAI+ will save clinicians the time-consuming manual effort that comes with other auto-contouring tools.”

Learn more about Contour ProtégéAI+.

About MIM Software Inc.

MIM Software Inc. is a privately held company headquartered in Cleveland, OH, with international offices in Beijing, Chengdu, and Brussels.

MIM Software sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. The company’s products are used in over 3,500 centers worldwide.

MIM Software is committed to enhancing patient care by providing customer-centered and innovative imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Theranostics, Interventional Radiology, and Urology.

Contact Information

Bill Carruthers
Product Marketing Manager
bcarruthers@mimsoftware.com
216-455-0610

Jim Janek
Director of Marketing
jjanek@mimsoftware.com
440-212-4455

Related Files

mim softare logo.png
contour-protegeai-plus_logo.png

SOURCE: MIM Software Inc.

View source version on accesswire.com:
https://www.accesswire.com/812891/mim-software-inc-announces-fda-clearance-of-contour-protgai

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

4 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

7 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

7 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

7 hours ago